273 related articles for article (PubMed ID: 31985309)
1. Safety considerations with combination therapies for psoriasis.
Nakamura M; Koo J
Expert Opin Drug Saf; 2020 Apr; 19(4):489-498. PubMed ID: 31985309
[No Abstract] [Full Text] [Related]
2. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS
JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis.
Bissonnette R; Kerdel F; Naldi L; Papp K; Galindo C; Langholff W; Tang KL; Szapary P; Fakharzadeh S; Srivastava B; Goyal K; Gottlieb AB
J Drugs Dermatol; 2017 Oct; 16(10):1002-1013. PubMed ID: 29036254
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of treatment modalities for psoriasis.
Tristani-Firouzi P; Krueger GG
Cutis; 1998 Feb; 61(2 Suppl):11-21. PubMed ID: 9787987
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy in psoriasis: an evidence-based review.
Gustafson CJ; Watkins C; Hix E; Feldman SR
Am J Clin Dermatol; 2013 Feb; 14(1):9-25. PubMed ID: 23329077
[TBL] [Abstract][Full Text] [Related]
6. Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America.
Papp KA; Gooderham M; Beecker J; Lynde CW; Delorme I; Dei-Cas I; Albrecht L; Rampakakis E; Sampalis JS; Vieira A; Hussein S; Chambenoit O; Rihakova L
BMC Dermatol; 2019 Jun; 19(1):9. PubMed ID: 31226985
[TBL] [Abstract][Full Text] [Related]
7. Use of biologic agents in combination with other therapies for the treatment of psoriasis.
Cather JC; Crowley JJ
Am J Clin Dermatol; 2014 Dec; 15(6):467-78. PubMed ID: 25373522
[TBL] [Abstract][Full Text] [Related]
8. Practice of phototherapy in the treatment of moderate-to-severe psoriasis.
Nguyen T; Gattu S; Pugashetti R; Koo J
Curr Probl Dermatol; 2009; 38():59-78. PubMed ID: 19710550
[TBL] [Abstract][Full Text] [Related]
9. Combining Topical Psoriasis Treatment to Enhance Systemic and Phototherapy: A Review of the Literature.
Bagel J; Gold LS
J Drugs Dermatol; 2017 Dec; 16(12):1209-1222. PubMed ID: 29240856
[TBL] [Abstract][Full Text] [Related]
10. Current challenges and emerging drug delivery strategies for the treatment of psoriasis.
Hoffman MB; Hill D; Feldman SR
Expert Opin Drug Deliv; 2016 Oct; 13(10):1461-73. PubMed ID: 27164301
[TBL] [Abstract][Full Text] [Related]
11. Safety concerns with current treatments for psoriasis in the elderly.
Di Caprio R; Caiazzo G; Cacciapuoti S; Fabbrocini G; Scala E; Balato A
Expert Opin Drug Saf; 2020 Apr; 19(4):523-531. PubMed ID: 32056449
[No Abstract] [Full Text] [Related]
12. Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and cost.
Feldman SR; Garton R; Averett W; Balkrishnan R; Vallee J
Expert Opin Pharmacother; 2003 Sep; 4(9):1525-33. PubMed ID: 12943482
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with tumor necrosis factor inhibitors in psoriasis treatment.
Famenini S; Wu JJ
Cutis; 2013 Sep; 92(3):140-7. PubMed ID: 24153143
[TBL] [Abstract][Full Text] [Related]
14. Biologics in pediatric psoriasis - efficacy and safety.
Dogra S; Mahajan R
Expert Opin Drug Saf; 2018 Jan; 17(1):9-16. PubMed ID: 29022425
[TBL] [Abstract][Full Text] [Related]
15. Current and Under Development Treatment Modalities of Psoriasis: A Review.
Albaghdadi A
Endocr Metab Immune Disord Drug Targets; 2017; 17(3):189-199. PubMed ID: 28782467
[TBL] [Abstract][Full Text] [Related]
16. The Evolving Landscape of Psoriasis Treatment.
Armstrong AW; Gordon KB; Menter MA; Wu JJ
Semin Cutan Med Surg; 2018 Feb; 37(2S):S39-S43. PubMed ID: 29614136
[TBL] [Abstract][Full Text] [Related]
17. Emerging oral drugs for psoriasis.
Mahmood T; Zaghi D; Menter A
Expert Opin Emerg Drugs; 2015 Jun; 20(2):209-20. PubMed ID: 25643592
[TBL] [Abstract][Full Text] [Related]
18. Combining the new biologic agents with our current psoriasis armamentarium.
Lebwohl M
J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S118-24. PubMed ID: 12894135
[TBL] [Abstract][Full Text] [Related]
19. Are biosimilars approved for use in psoriasis safe enough to replace leading biologic therapies? A review.
Reynolds KA; Pithadia DJ; Lee EB; Han G; Wu JJ
Expert Opin Drug Saf; 2020 Apr; 19(4):459-466. PubMed ID: 32116071
[No Abstract] [Full Text] [Related]
20. Emerging landscape in psoriasis management: From topical application to targeting biomolecules.
Rapalli VK; Singhvi G; Dubey SK; Gupta G; Chellappan DK; Dua K
Biomed Pharmacother; 2018 Oct; 106():707-713. PubMed ID: 29990862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
